Intrusion Inc. Reports Revenue of $1.7 Million in the Third Quarter of 2017
Nov 13, 2017 21:05 pm UTC| Business
RICHARDSON, Texas, Nov. 13, 2017 -- Intrusion Inc. (OTCQB:INTZ), (“Intrusion”) announced today financial results for the three and nine months ended September 30, 2017. Intrusion’s net income was $568 thousand in the...
Nov 13, 2017 21:04 pm UTC| Business
SAN FRANCISCO, Nov. 13, 2017 -- Hagens Berman Sobol Shapiro LLP reminds investors in Skechers USA, Inc. (NYSE:SKX) of the December 22, 2017 Lead Plaintiff deadline in the securities class action alleging improper...
CohBar, Inc. Announces Third Quarter 2017 Financial Results
Nov 13, 2017 21:03 pm UTC| Business
MENLO PARK, Calif., Nov. 13, 2017 -- CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U) (“CohBar” or the “Company”), an innovative biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat...
Everspin Announces Third Quarter 2017 Financial Results
Nov 13, 2017 21:03 pm UTC| Business
CHANDLER, Ariz., Nov. 13, 2017 -- Everspin Technologies, Inc., (Nasdaq:MRAM), today announced the company’s third quarter 2017 financial results for the quarter ended September 30, 2017. Revenue for the third quarter...
ProQR Announces Proposed Public Offering of Ordinary Shares
Nov 13, 2017 21:01 pm UTC| Business
LEIDEN, the Netherlands, Nov. 13, 2017 -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a biopharmaceutical company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe...
Brooks Automation to Present at the Stifel 2017 Healthcare Conference
Nov 13, 2017 21:01 pm UTC| Business
CHELMSFORD, Mass., Nov. 13, 2017 -- Brooks Automation, Inc. (Nasdaq:BRKS) announced today that the company will present at the Stifel 2017 Healthcare Conference at the Lotte New York Palace Hotel, New York. Steve...
TearLab Corporation Reports Third Quarter and September Year-To-Date 2017 Financial Results
Nov 13, 2017 21:01 pm UTC| Business
SAN DIEGO, Nov. 13, 2017 -- TearLab Corporation (OTCQB:TEAR) (TSX:TLB) (“TearLab” or the “Company”) today reported its consolidated financial results for the third quarter and nine months ended September 30, 2017. All...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update